spacer
The Healthcare Sales & Marketing Network celebrates 28 years serving the medical sales & marketing community.Connecting Medical Sales Reps with MedTech/BioPharma Recruiters and Independent Reps with and New Product LinesConnecting Medical Sales Reps with MedTech/BioPharma Recruiters and Independent Reps with and New Product Lines

Healthcare News Roundup: Biopharmaceutical

 HSMN NewsFeed - 23 Apr 2010
Teva Provides Update on Generic Protonix(R) Litigation
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 23 Apr 2010
Merz Aesthetics Announces FDA Approval of Asclera(TM) (Polidocanol) Injection, First Sclerosant to Treat Small Varicose Veins in 60 Years
Biopharmaceuticals FDA
 HSMN NewsFeed - 23 Apr 2010
UCB Receives Complete Response Letter from U.S. FDA Regarding Neupro(R) (Rotigotine)
Biopharmaceuticals Drug Delivery Neurology FDA
 HSMN NewsFeed - 23 Apr 2010
INTUNIV(TM) - Shire Files Suit Against Teva Pharmaceuticals USA, Inc. and Teva Pharmaceutical Industries, Ltd.
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 23 Apr 2010
InteKrin Therapeutics Appoints Roman Skowronski, MD, PhD as Vice President of Clinical Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 23 Apr 2010
Genentech Submits Supplemental Application to FDA for Herceptin in Advanced HER2-Positive Stomach Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 22 Apr 2010
Ampio Pharmaceuticals to Acquire DMI Biosciences, Inc.
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 22 Apr 2010
pHase Pharmaceuticals Announces New Venture
Biopharmaceuticals Personnel
 HSMN NewsFeed - 22 Apr 2010
SV Life Sciences Adds Health Care Services Veteran Paul Wallace as Venture Partner
Biopharmaceuticals Devices Venture Capital Personnel
 HSMN NewsFeed - 22 Apr 2010
Aragon Pharmaceuticals Secures $22 Million in Series B Financing
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 22 Apr 2010
Actelion Pharmaceuticals Announces Commercial Availability of Epoprostenol for Injection for the Treatment of Pulmonary Arterial Hypertension
Biopharmaceuticals
 HSMN NewsFeed - 22 Apr 2010
Novartis Receives US FDA Approval for Zortress(R) (everolimus) to Prevent Organ Rejection in Adult Kidney Transplant Recipients
Biopharmaceuticals FDA
 HSMN NewsFeed - 21 Apr 2010
Akorn Announces FDA Approval to Re-Launch Erythromycin Ophthalmic Ointment USP 3.5 g
Biopharmaceuticals Ophthalmology FDA
 HSMN NewsFeed - 21 Apr 2010
AVI BioPharma Appoints David Boyle Interim President and CEO
Biopharmaceuticals Personnel
 HSMN NewsFeed - 21 Apr 2010
Valeant to Acquire Pharmaceutical Company in Brazil
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 21 Apr 2010
Merck Obtains Exclusive Rights to Market and Distribute MassBiologics' Tetanus-Diphtheria (Td) Vaccine in the U.S.
Biopharmaceuticals Licensing Distribution
 HSMN NewsFeed - 20 Apr 2010
Gemin X Announces $16 Million Series D Financing
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 20 Apr 2010
Human Genome Sciences and GlaxoSmithKline Announce Topline 76-Week Results of Phase 3 Trial of BENLYSTA in Systemic Lupus Erythematosus
Biopharmaceuticals
 HSMN NewsFeed - 19 Apr 2010
Hospira and Javelin Pharmaceuticals Enter Into Definitive Merger Agreement for Hospira to Acquire Javelin Pharmaceuticals; Hospira Will Initiate Tender Offer
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 19 Apr 2010
Myriad Pharmaceuticals Announces Termination of Merger Agreement With Javelin Pharmaceuticals
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 19 Apr 2010
BioMarin Launches Firdapse in the European Union
Biopharmaceuticals
 HSMN NewsFeed - 19 Apr 2010
Javelin Pharmaceuticals Announces Termination of Merger Agreement with Myriad Pharmaceuticals, Cancels Special Meeting of Stockholders
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 19 Apr 2010
Sagent Pharmaceuticals Announces FDA Approval of Mesna Injection
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 19 Apr 2010
Mylan Announces Approval Under PEPFAR for Generic Version of Videx(R) EC HIV Treatment
Biopharmaceuticals Generics HIV/AIDS FDA
 HSMN NewsFeed - 19 Apr 2010
Roxane Laboratories, Inc. Announces the Launch of Imipramine Pamoate Capsules
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 19 Apr 2010
Human Genome Sciences Announces Withdrawal of European Marketing Authorization Application For JOULFERON(R) (ZALBIN) For the Treatment of Chronic Hepatitis C
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 19 Apr 2010
EpiCept Announces Commercial Launch of Ceplene(R) in the United Kingdom
Biopharmaceuticals Oncology
 HSMN NewsFeed - 16 Apr 2010
Alexion's Soliris(R) (Eculizumab) Receives Marketing Approval in Japan for Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH)
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 15 Apr 2010
Comparative Trial of Canyon's Iprivask(R) (Desirudin) with Standard of Care Shows Favorable Outcomes for Thrombosis Prophylaxis in Surgery Patients with HIT
Biopharmaceuticals
 HSMN NewsFeed - 15 Apr 2010
Impax Pharmaceuticals Completes Enrollment in APEX-PD Phase III Trial of IPX066 in Parkinson's Disease
Biopharmaceuticals Neurology
 HSMN NewsFeed - 15 Apr 2010
John P. Dugan, Founder and Chairman of PDI, Inc., To Retire
Biopharmaceuticals Personnel
 HSMN NewsFeed - 15 Apr 2010
Dendreon Appoints Richard Ranieri as Senior Vice President of Human Resources
Biopharmaceuticals Personnel
 HSMN NewsFeed - 15 Apr 2010
Taligen Announces Key Additions to Management Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 15 Apr 2010
Taligen Appoints Industry Leader, John Maraganore, as Director
Biopharmaceuticals Personnel
 HSMN NewsFeed - 15 Apr 2010
REMICADE(R) Study Results Show Greater Steroid-Free Remission and Mucosal Healing Compared With Conventional Immunomodulator Azathioprine in Treatment of Crohn's Disease
Biopharmaceuticals Gastroenterology
 HSMN NewsFeed - 15 Apr 2010
Silence Therapeutics Appoints Max Herrmann as Chief Financial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 14 Apr 2010
Sagent Pharmaceuticals Announces FDA Approval of Granisetron Hydrochloride Injection, USP
Biopharmaceuticals Generics Oncology FDA
 HSMN NewsFeed - 14 Apr 2010
QRxPharma Successfully Completes Pivotal Phase 3 Combination Rule Study for MoxDuo(R)IR in Patients with Post-Surgical Pain
Biopharmaceuticals Surgery
 HSMN NewsFeed - 14 Apr 2010
Paul Westberg Joins Versartis as Senior Vice President, Business Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 14 Apr 2010
POZEN Enters into Settlement Agreement With Teva Regarding Paragraph IV Patent Litigation
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 13 Apr 2010
FDA Maintains Essential Use Status of Combivent(R) (ipratropium bromide and albuterol sulfate) Inhalation Aerosol Through 2013
Biopharmaceuticals FDA
 HSMN NewsFeed - 13 Apr 2010
Baxter and New York-Presbyterian/Weill Cornell Announce 18-Month Data from Phase II Study of GAMMAGARD in Patients with Alzheimer's Disease
Biopharmaceuticals Neurology
 HSMN NewsFeed - 13 Apr 2010
FDA Approves New Drug Application for PANCREAZE(TM)
Biopharmaceuticals FDA
 HSMN NewsFeed - 13 Apr 2010
K-V Pharmaceutical Appoints New Chief Financial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 13 Apr 2010
Penwest and Endo Enter Into Agreement With Barr to Settle Patent Litigation Over Opana(R) ER
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 13 Apr 2010
New Data Show Sustained 5-Year Benefit of Neupro(R) (Rotigotine Transdermal System) for Symptoms of Restless Legs Syndrome
Biopharmaceuticals Neurology Drug Delivery
 HSMN NewsFeed - 13 Apr 2010
Galen Partners Invests in Nautilus Neurosciences, Inc.
Biopharmaceuticals Neurology Venture Capital
 HSMN NewsFeed - 13 Apr 2010
Inspire Appoints Andrew Koven as Executive Vice President and Chief Administrative and Legal Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 12 Apr 2010
Affymax Names John A. Orwin President and Chief Operating Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 12 Apr 2010
Myriad Pharmaceuticals Receives Notice of Javelin's Intent to Terminate Merger Agreement
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 12 Apr 2010
Javelin Pharmaceuticals Delivers Notice of Intent to Terminate Merger Agreement with Myriad Pharmaceuticals
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 12 Apr 2010
Xcellerex Announces Appointment of Guy Broadbent as President and Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 12 Apr 2010
Sinapis Pharma Receives IND Approval from the FDA
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 12 Apr 2010
Ardea Biosciences, Inc. Announces Appointment of Stephen R. Davis as Executive Vice President and Chief Operating Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 12 Apr 2010
FORMA Therapeutics Appoints Robert Forrester Chief Operating Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 12 Apr 2010
Somaxon Pharmaceuticals Appoints Chief Financial Officer and Announces Senior Leadership Promotions
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 12 Apr 2010
QLT Names Dipak Panigrahi, M.D., as Chief Medical Officer
Biopharmaceuticals Ophthalmology Personnel
 HSMN NewsFeed - 9 Apr 2010
Stellar Pharmaceuticals Announces Steven H. Goldman Rejoins Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 9 Apr 2010
Cephalon Completes Acquisition of Swiss Pharmaceutical Company Mepha
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 9 Apr 2010
CTI Receives Complete Response Letter from the FDA for Pixantrone NDA; CTI to File for Expanded Access for Patients With Relapsed or Refractory Aggressive Non-Hodgkin's Lymphoma
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 8 Apr 2010
Perrigo Wins Unfair Competition Case
Biopharmaceuticals Litigation
 HSMN NewsFeed - 8 Apr 2010
Aeterna Zentaris Announces Initiation of Phase 3 Registration Trial with Perifosine in Refractory Advanced Colorectal Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 7 Apr 2010
Teva Announces Final Approval of Generic Hyzaar(R) and Cozaar(R)
Biopharmaceuticals Generics Cardiology FDA
 HSMN NewsFeed - 7 Apr 2010
Tris Pharma Announces Key Executive Hiring of Vice President of Corporate Development
Biopharmaceuticals Drug Delivery Personnel
 HSMN NewsFeed - 7 Apr 2010
Idera Pharmaceuticals Announces Management Appointments and Promotion
Biopharmaceuticals Personnel
 HSMN NewsFeed - 7 Apr 2010
Achaogen Completes $56 Million Series C Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 7 Apr 2010
Recordati Signs Co-Marketing Agreement With Esteve in Spain for Pitavastatin
Biopharmaceuticals Cardiology Licensing
 HSMN NewsFeed - 6 Apr 2010
Artepharm Global Announces Addition to Its Management Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 6 Apr 2010
ZIOPHARM Elects George B. Abercrombie, former CEO of Hoffmann-La Roche, to Board of Directors
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 6 Apr 2010
Allon Therapeutics Announces Davunetide Receives FDA Fast Track Status for Treatment of Progressive Supranuclear Palsy
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 6 Apr 2010
Genta's Tesetaxel Granted Fast Track Designation by FDA for Advanced Gastric Cancer
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 6 Apr 2010
Cempra Announces Expansion of Clinical Management Team to Advance Leading Antibacterial Clinical Programs TAKSTA(TM) and CEM-101
Biopharmaceuticals Personnel
 HSMN NewsFeed - 6 Apr 2010
AcelRx Pharmaceuticals Names Richard King Chief Executive Officer
Biopharmaceuticals Drug Delivery Personnel
 HSMN NewsFeed - 5 Apr 2010
ULURU Inc. Announces the Appointment of Dr. Jeffrey A. Stone to the Board of Directors
Biopharmaceuticals Drug Delivery Wound Care Personnel
 HSMN NewsFeed - 5 Apr 2010
Cephalon Completes Acquisition of Ception Therapeutics
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 5 Apr 2010
Par Pharmaceutical Enters Into Agreement With sanofi-aventis to Settle Patent Litigation Over Generic Eloxatin(R)
Biopharmaceuticals Generics Oncology Litigation
 HSMN NewsFeed - 5 Apr 2010
Perrigo and Partner Cobrek Announce Settlement of Luxiq(R) Patent Litigation
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 5 Apr 2010
Perrigo and Partner Cobrek Launch Generic Version of Evoclin(R) and Announce Settlement of Related Litigation
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 5 Apr 2010
Keryx Receives FDA Fast Track Designation for KRX-0401 (Perifosine) for the Treatment of Refractory Advanced Colorectal Cancer
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 5 Apr 2010
Qutenza(R) (capsaicin) 8% Patch for Treatment of Post-Shingles Pain Now Available
Biopharmaceuticals Drug Delivery
 HSMN NewsFeed - 5 Apr 2010
OXiGENE Appoints Tamar D. Howson and Peter J. Langecker to Its Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 5 Apr 2010
Tioga Pharmaceuticals Receives Special Protocol Assessment Agreement From FDA for Phase 3 Trials of Asimadoline in Irritable Bowel Syndrome
Biopharmaceuticals Gastroenterology FDA
 HSMN NewsFeed - 5 Apr 2010
Altheos Completes $20 Million Series A Financing to Develop Next-Generation Glaucoma Treatment
Biopharmaceuticals Ophthalmology Venture Capital
 HSMN NewsFeed - 5 Apr 2010
Selecta Closes $15 Million Series C Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 1 Apr 2010
Allergan and Serenity Pharmaceuticals Enter into Global Agreement for the Treatment of Nocturia
Biopharmaceuticals Urology
 HSMN NewsFeed - 1 Apr 2010
MDRNA, Inc. Acquires Cequent Pharmaceuticals
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 1 Apr 2010
AMAG Pharmaceuticals and Takeda Pharmaceutical Company Announce Strategic Collaboration for Feraheme(R) in All Therapeutic Indications in Select Ex-US Territories, Including Europe
Biopharmaceuticals Licensing
 HSMN NewsFeed - 1 Apr 2010
Teva Settles Generic Eloxatin Litigation
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 31 Mar 2010
Ambrilia Biopharma Announces Changes to Its Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 31 Mar 2010
Eisai Submits Marketing Authorisation Application for Approval of Eribulin Mesylate in Europe, Based on Significant Overall Survival in Late Stage Breast Cancer
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 30 Mar 2010
Genzyme Creates Chief Operating Officer Position
Biopharmaceuticals Personnel
 HSMN NewsFeed - 30 Mar 2010
PharmAthene Appoints Eric I. Richman as President and Chief Operating Officer and Announces Senior Management Promotions
Biopharmaceuticals Personnel
 HSMN NewsFeed - 30 Mar 2010
Biodel Announces Senior Leadership Changes
Biopharmaceuticals Personnel
 HSMN NewsFeed - 30 Mar 2010
AstraZeneca and Abbott Receive FDA Complete Response Letter on CERTRIAD(TM) New Drug Application
Biopharmaceuticals FDA
 HSMN NewsFeed - 30 Mar 2010
Medivation Announces Reduction in Workforce
Biopharmaceuticals Neurology
 HSMN NewsFeed - 30 Mar 2010
Cadence Pharmaceuticals Appoints Michael L. Eagle to its Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 29 Mar 2010
Oxygen Biotherapeutics Now Marketing New Formulation of Dermacyte(TM) Oxygen Concentrate
Biopharmaceuticals Dermatology
 HSMN NewsFeed - 29 Mar 2010
Pro-Pharmaceuticals Licenses to PROCAPS S.A. Exclusive Marketing and Distribution Rights to Commercialize DAVANAT(R) to Treat Cancer in Colombia, South America
Biopharmaceuticals Oncology Licensing
 HSMN NewsFeed - 29 Mar 2010
Auxilium Announces Promotion of Benjamin Del Tito Jr., Ph.D. to Executive Vice President, Regulatory Affairs and Project Management
Biopharmaceuticals Personnel
 HSMN NewsFeed - 29 Mar 2010
Merck Serono: Erbitux Granted Extended Use in Japan for 1st-Line Treatment of mCRC Patients with KRAS Wild-Type Tumors
Biopharmaceuticals Oncology
 HSMN NewsFeed - 26 Mar 2010
FDA Approves Zyclara(TM) (imiquimod) Cream, 3.75% for the Treatment of Actinic Keratoses
Biopharmaceuticals Dermatology FDA
 HSMN NewsFeed - 26 Mar 2010
VIVUS Announces Date of FDA Advisory Committee Review of Qnexa(R) for the Treatment of Obesity
Biopharmaceuticals
 HSMN NewsFeed - 26 Mar 2010
Biovail Acquires AMPAKINE(R) Compounds for Treatment of Respiratory Depression
Biopharmaceuticals Acquisitions
 HSMN NewsFeed - 26 Mar 2010
Cortex Sells Selected AMPAKINE Compounds and Rights to Respiratory Depression Indication to Biovail
Biopharmaceuticals Acquisitions
 HSMN NewsFeed - 25 Mar 2010
Proteostasis Therapeutics Announces Additions of Key Executives
Biopharmaceuticals Personnel
 HSMN NewsFeed - 25 Mar 2010
Teva Announces Tentative Approval of Generic Argatroban(R) Injection
Biopharmaceuticals Cardiology Generics FDA
 HSMN NewsFeed - 25 Mar 2010
Declaratory Relief Complaint for Patent Infringement Under Patent Based on Manufacture, Marketing and Sale of Arzerra
Biopharmaceuticals Oncology Litigation
 HSMN NewsFeed - 25 Mar 2010
AVI BioPharma Announces Pending Changes to Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 25 Mar 2010
Santarus Announces Completion of Enrollment in U.S. Phase III Clinical Study for Budesonide MMX
Biopharmaceuticals Drug Delivery Gastroenterology
 HSMN NewsFeed - 24 Mar 2010
ondansetron RapidFilm(TM) Approved in 16 European Countries
Biopharmaceuticals Drug Delivery Oncology Regulatory
 HSMN NewsFeed - 24 Mar 2010
FDA Approves XIFAXAN(R) 550 MG Tablets for Reduction in Risk of Overt Hepatic Encephalopathy (HE) Recurrence
Biopharmaceuticals FDA
 HSMN NewsFeed - 24 Mar 2010
Epizyme Expands Leadership Team, Appointing Robert Gould, Ph.D. as CEO and Jason Rhodes as EVP and CBO
Biopharmaceuticals Personnel
 HSMN NewsFeed - 23 Mar 2010
Once-Daily MIRAPEX ER Now Approved by FDA for Both Early and Advanced Parkinson's Disease
Biopharmaceuticals FDA Neurology
 HSMN NewsFeed - 23 Mar 2010
Oncothyreon announces temporary suspension of Stimuvax clinical trials by Merck Serono
Biopharmaceuticals Oncology
 HSMN NewsFeed - 23 Mar 2010
Rib-X Appoints Mark Leuchtenberger as President and CEO
Biopharmaceuticals Personnel
 HSMN NewsFeed - 23 Mar 2010
APP Pharmaceuticals Receives Approval for Indomethacin for Injection
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 22 Mar 2010
PhytoMedical Announces the Appointment of Dr. James F. Lynch as President and CEO
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 19 Mar 2010
Astellas Announces Changes to Director Nominees for Election to OSI Pharmaceuticals' Board of Directors
Biopharmaceuticals Mergers & Acquisitions Personnel
 HSMN NewsFeed - 19 Mar 2010
Levact(R) (bendamustine) Recommended for Approval in Europe for Treating Blood Cancers
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 19 Mar 2010
OSI Pharmaceuticals Announces That Tarceva(R) Received a Positive Opinion from Health Authorities in the European Union for First-Line Maintenance Use in Advanced Non-Small Cell Lung Cancer
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 18 Mar 2010
Somaxon Announces FDA Approval of Silenor(R) (doxepin) for the Treatment of Insomnia
Biopharmaceuticals FDA
 HSMN NewsFeed - 18 Mar 2010
Dr. Thomas Hofstaetter Named President and CEO of VaxInnate; Dr. Alan Shaw Assumes New Role as Chief Scientific Officer and Chairman of the Board
Biopharmaceuticals Personnel
 HSMN NewsFeed - 18 Mar 2010
Teva to Acquire ratiopharm
Biopharmaceuticals Generics Mergers & Acquisitions
 HSMN NewsFeed - 17 Mar 2010
King Pharmaceuticals Announces US Department of Justice Settlement
Biopharmaceuticals
 HSMN NewsFeed - 17 Mar 2010
The Medicines Company Expands a Nationwide Recall for Certain Lots of Cleviprex(R) That May Contain Particulate Matter
Biopharmaceuticals Product Recall
 HSMN NewsFeed - 17 Mar 2010
ABRAXANE Meets Primary Endpoint in Phase 3 Trial for Advanced Non-Small Cell Lung Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 16 Mar 2010
Genentech Submits Supplemental Biologics License Application for ACTEMRA(R) (tocilizumab) for Prevention of Structural Joint Damage and Improvement of Physical Function in Rheumatoid Arthritis
Biopharmaceuticals FDA
 HSMN NewsFeed - 16 Mar 2010
Promedior Closes $12 Million Series C Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 15 Mar 2010
Inadequate Response to Clopidogrel Leads to Higher Incidence of Major Adverse Cardiac Events in Patients Who have Undergone PCI
Biopharmaceuticals Diagnostics Cardiology
 HSMN NewsFeed - 15 Mar 2010
Ranbaxy Announces Settlement of Actos(R) (Pioglitazone Hydrochloride) Patent Litigation
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 15 Mar 2010
Timothy Barabe Appointed Chief Financial Officer of Affymetrix
Biopharmaceuticals Personnel
 HSMN NewsFeed - 15 Mar 2010
Amylin, Lilly and Alkermes Receive Complete Response Letter From FDA for Exenatide Once Weekly Submission
Biopharmaceuticals
 HSMN NewsFeed - 12 Mar 2010
Endo Pharmaceuticals Announces Appointment of New Chief Operating Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 12 Mar 2010
Genetix Pharmaceuticals Secures $35M in Series B Funding
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 12 Mar 2010
Manhattan Pharmaceuticals Completes Merger Transaction With Ariston Pharmaceuticals
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 12 Mar 2010
Genentech Provides Update on Phase III Study of Avastin in Men With Late Stage Prostate Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 11 Mar 2010
FDA Grants Bayer HealthCare Pharmaceuticals Orphan Drug Designation for Investigational Ciprofloxacin Dry Powder Inhaler for the Treatment of Cystic Fibrosis
Biopharmaceuticals Drug Delivery FDA
 HSMN NewsFeed - 11 Mar 2010
sanofi-aventis Successfully Completes the Acquisition of Chattem, Inc.
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 11 Mar 2010
Portola Pharmaceuticals Announces Senior Management and Board Changes
Biopharmaceuticals Personnel
 HSMN NewsFeed - 10 Mar 2010
Cerulean Pharma Inc. Appoints Two Senior Executives to Management Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 10 Mar 2010
Watson Announces Actos(R) Patent Challenge Settlement
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 10 Mar 2010
Cytokinetics Announces Orphan Drug Designation Granted to CK-2017357 for the Treatment of Amyotrophic Lateral Sclerosis
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 10 Mar 2010
Diamyd Medical: Diamyd US Phase III Study Well under Way
Biopharmaceuticals Endocrinology
 HSMN NewsFeed - 9 Mar 2010
Bristol-Myers Squibb and AstraZeneca Announce the Commencement of the Saxagliptin Assessment of Vascular Outcomes Recorded in Patients with Diabetes Mellitus Trial (SAVOR-TIMI 53)
Biopharmaceuticals Cardiology Endocrinology
 HSMN NewsFeed - 9 Mar 2010
Teva Announces the Appointment of Dr. Philip Frost as Chairman of Its Board of Directors
Biopharmaceuticals Generics Personnel
 HSMN NewsFeed - 9 Mar 2010
Human Genome Sciences Appoints David P. Southwell Executive Vice President and Chief Financial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 9 Mar 2010
INSYS Therapeutics, Inc. Announces Positive Phase III Efficacy Trial Results for Fentanyl Sublingual Spray
Biopharmaceuticals Drug Delivery
 HSMN NewsFeed - 8 Mar 2010
Omthera Pharmaceuticals, Inc. Closes a $6.5M Series A led by Sofinnova Partners to Advance Epanova, a Prescription Omega 3 Therapy
Biopharmaceuticals Cardiology Venture Capital
 HSMN NewsFeed - 8 Mar 2010
Afraxis Appoints Chief Scientific Officer and Vice President, Corporate Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 8 Mar 2010
Auxilium Announces Availability of XIAFLEX(TM) for the Treatment of Dupuytren's Contracture
Biopharmaceuticals
 HSMN NewsFeed - 8 Mar 2010
EUSA Pharma Completes Establishment of Commercial Infrastructure With Appointment of President for Europe and International Region
Biopharmaceuticals Personnel
 HSMN NewsFeed - 5 Mar 2010
XenoPort Restructures to Focus on Key Programs
Biopharmaceuticals
 HSMN NewsFeed - 5 Mar 2010
La Jolla Pharmaceutical Announces Termination of Merger Agreement with Adamis Pharmaceuticals
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 4 Mar 2010
iBio Appoints Vidadi Yusibov, Ph.D. Chief Scientific Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 4 Mar 2010
Watson Announces Agreement to Acquire U.S. Rights to Columbia Laboratories' CRINONE(R) Progesterone Gel Product Line
Biopharmaceuticals Acquisitions
 HSMN NewsFeed - 3 Mar 2010
EKR Therapeutics Appoints John Bailye as Interim President & Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 3 Mar 2010
Abbott to Collaborate With GSK on Molecular Diagnostic Test to Select Candidate Patients for Future Skin Cancer Immunotherapy
Diagnostics Biopharmaceuticals Oncology
 HSMN NewsFeed - 3 Mar 2010
La Jolla Pharmaceutical Announces Delisting from Nasdaq and Failure to Get Stockholder Vote for Merger
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 3 Mar 2010
Novo Nordisk Receives FDA Approval for Norditropin(R) FlexPro(R) for Growth Hormone Treatment
Biopharmaceuticals Devices Drug Delivery FDA
 HSMN NewsFeed - 3 Mar 2010
Edward R. Teitel, MD, JD Becomes Chairman of Urigen
Biopharmaceuticals Urology Personnel
 HSMN NewsFeed - 3 Mar 2010
Bristol-Myers Squibb and Allergan Enter Global Agreement on Investigational Neuropathic Pain Medicine
Biopharmaceuticals Neurology Licensing
 HSMN NewsFeed - 3 Mar 2010
Pfizer And Medivation Announce Results From Two Phase 3 Studies In Dimebon (latrepirdine*) Alzheimer's Disease Clinical Development Program
Biopharmaceuticals Neurology
 HSMN NewsFeed - 3 Mar 2010
NicOx and Bausch & Lomb Announce Worldwide Licensing Agreement for NCX 116
Biopharmaceuticals Ophthalmology Licensing
 HSMN NewsFeed - 3 Mar 2010
Sanofi-Aventis and Novalar Enter Exclusive License Agreement to Commercialize OraVerse(R) in Germany
Biopharmaceuticals Licensing
 HSMN NewsFeed - 3 Mar 2010
Solasia Pharma and Kyowa Hakko Kirin Enter Into a License Agreement for SP-01 (Sancuso) in Asia
Biopharmaceuticals Licensing
 HSMN NewsFeed - 2 Mar 2010
OSI Pharmaceuticals Board of Directors to Review Astellas' Unsolicited Tender Offer
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 2 Mar 2010
Bristol-Myers Squibb Names Lamberto Andreotti CEO, Effective May 4; James Cornelius to Retire as CEO, Remain as Chairman
Biopharmaceuticals Personnel
 HSMN NewsFeed - 2 Mar 2010
Teva Announces Favorable Court Ruling in Generic Hyzaar(R) and Cozaar(R) Litigation
Biopharmaceuticals Litigation Generics Cardiology
 HSMN NewsFeed - 2 Mar 2010
Impax Laboratories Receives Final FDA Approval for Generic FLOMAX(R) 0.4mg Capsules and Immediately Commences Shipment
Biopharmaceuticals FDA Generics
 HSMN NewsFeed - 2 Mar 2010
iBio Appoints Philip K. Russell, M.D. to Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 2 Mar 2010
Catalyst Biosciences Appoints William J. Dawson Chief Financial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 2 Mar 2010
Orexigen(R) Therapeutics Appoints Peter Honig, M.D. to Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 2 Mar 2010
Astellas Pharma Inc. Commences Tender Offer to Acquire All Outstanding Shares of OSI Pharmaceuticals for $52 per Share in Cash
Biopharmaceuticals Mergers & Acquisitions Litigation
 HSMN NewsFeed - 2 Mar 2010
Antares Pharma Announces Completion of Patient Enrollment in Phase 3 Pivotal Trial of Anturol for the Treatment of Overactive Bladder
Biopharmaceuticals Urology Drug Delivery
 HSMN NewsFeed - 2 Mar 2010
InterMune Announces Submission of MAA for Pirfenidone for the Treatment of Patients With IPF
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 2 Mar 2010
FDA Approves EXALGO (Hydromorphone HCL) Extended-Release Tablets
Biopharmaceuticals FDA
 HSMN NewsFeed - 1 Mar 2010
FDA Advisory Committee Recommends Approval of Belatacept, an Investigational Agent for Prophylaxis of Acute Rejection in De Novo Kidney Transplant Patients
Biopharmaceuticals
 HSMN NewsFeed - 1 Mar 2010
OSI Pharmaceuticals Confirms Receipt of Unsolicited Proposal From Astellas Pharma
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 1 Mar 2010
Transdel Pharmaceuticals Appoints Terry Nida as Chief Business Officer
Biopharmaceuticals Drug Delivery Personnel
 HSMN NewsFeed - 1 Mar 2010
Cook Pharmica Names Veda Walcott Vice President of Quality
Devices Biopharmaceuticals Personnel
 HSMN NewsFeed - 1 Mar 2010
Gentium Announces Management Changes and Corporate Restructuring
Biopharmaceuticals Personnel
 HSMN NewsFeed - 1 Mar 2010
AEterna Zentaris Receives Positive Opinion for Orphan Medicinal Product Designation for Perifosine for the Treatment of Multiple Myeloma from the Committee for Orphan Medicinal Products of the European Medicines Agency
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 1 Mar 2010
FDA Accepts VIAject(R) NDA for Review
Biopharmaceuticals Endocrinology FDA
 HSMN NewsFeed - 1 Mar 2010
Stephen Hitchcock to Head Drug Discovery at Envoy Therapeutics
Biopharmaceuticals Personnel
 HSMN NewsFeed - 1 Mar 2010
AstraZeneca Exercises Option to Acquire Merck's Interest in Partnership Products
Biopharmaceuticals Acquisitions
 HSMN NewsFeed - 1 Mar 2010
Inspire Elects George Abercrombie to Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 1 Mar 2010
Astellas Pharma Inc. Offers to Acquire OSI Pharmaceuticals for $52.00 Per Share in Cash
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 1 Mar 2010
Merck KGaA and Millipore Announce Transaction - Video Interview with Merck CEO
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 1 Mar 2010
ADVENTRX Receives Refuse to File Letter from FDA on ANX-530 New Drug Application
Biopharmaceuticals
Older Biopharmaceutical stories   Return to NewsFeed  
FindReps - screen and connect with rep candidates anonymously, in real time.

FindReps: Screen and connect with Medical Sales Rep candidates (Direct Reps and Independents) – anonymously, in real time.


RepJobs - Job Opportunities for Direct Sales Reps and New Product Lines for Independents!

RepJobs: Job Opportunities for Direct Sales Reps and New Product Lines for Independents!